Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Vietnam In Vitro Diagnostics (IVD) Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Growing Prevalence of Chronic and Infectious Diseases in Geriatric Population
3.2.1.2. Rising Awareness of Early Disease Diagnosis
3.2.2. Restraints
3.2.2.1. High Investment Deterring the Customers from Adopting Technologies
3.2.3. Opportunities
3.2.3.1. Advancement in Technology
3.2.4. Challenges
3.2.4.1. Stringent Government Regulation
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Vietnam In Vitro Diagnostics (IVD) Market Overview
4.1. Market Size & Forecast, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Type
4.2.1.1. Product
4.2.1.1.1. Reagents & Kits
4.2.1.1.2. Instruments
4.2.1.2. Service
4.2.1.2.1. Software
4.2.1.2.2. Testing Services
4.2.2. By Technology
4.2.2.1. Clinical Chemistry
4.2.2.2. Immunoassay/ Immunochemistry
4.2.2.3. Molecular Diagnostics
4.2.2.4. Hematology
4.2.2.5. Microbiology
4.2.2.6. Others (Coagulation & Hemostasis, Urinalysis)
4.2.3. By Application
4.2.3.1. Oncology
4.2.3.2. Infectious Disease
4.2.3.3. Diabetes
4.2.3.4. Cardiology
4.2.3.5. Nephrology
4.2.3.6. Others (Autoimmune disease, Drug testing/ pharmacogenomics)
4.2.4. By End User
4.2.4.1. Hospitals
4.2.4.2. Point of Care Testing
4.2.4.3. Laboratories
4.2.4.4. Academic Institutes
5. Competitive Landscape
5.1. List of Key Players and Their Offerings
5.2. Vietnam In Vitro Diagnostics (IVD) Company Market Share Analysis, 2022
5.3. Competitive Benchmarking, By Operating Parameters
5.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
6. Impact of Covid-19 on Vietnam In Vitro Diagnostics (IVD) Market
7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
7.1. Abbott
7.2. Danaher
7.3. Siemens Healthineers AG
7.4. Roche Diagnostics
7.5. Sysmex Corporation
7.6. Other Prominent Players
8. Key Strategic Recommendations
9. Research Methodology
9.1. Qualitative Research
9.1.1. Primary & Secondary Research
9.2. Quantitative Research
9.3. Market Breakdown & Data Triangulation
9.3.1. Secondary Research
9.3.2. Primary Research
9.4. Breakdown of Primary Research Respondents, By Region
9.5. Assumptions & Limitations
*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable